ArticleMolecular cancer therapeutics2023

Targeting Glutamine Metabolism with a Novel Na+/K+-ATPase Inhibitor RX108 in Hepatocellular Carcinoma.

Daoyan Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.